Global Veterinary Infectious Disease Diagnostics Market: Current Analysis and Forecast (2022-2028)

Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi, or parasites. The frequently occurring infectious diseases in animals are avian influenza virus and rabies virus. The diagnosis of infectious diseases is extremely difficult owing to the lack of symptoms in the animals. Therefore, huge research has been done in the sector, thus driving the growth of the market. Moreover, The rising adoption of animals and the increasing prevalence of infectious diseases among them are attributed to the market growth of the veterinary infectious disease diagnostics market. For instance, according to the Centers for Disease Control (CDC), Scientists estimate that more than 6 out of every 10 known infectious diseases in people can be spread from animals, and 3 out of every 4 new or emerging infectious diseases in people come from animals.

The Veterinary Infectious Disease Diagnostics Market is expected to grow at a steady rate of around 8% owing to the collaboration of private companies and governments. For instance, in January 2023, Alveo Technologies and the government of Barbados collaborate to co-develop advanced molecular disease diagnostics across multiple end markets.

Based on the technology, the market has been categorized into immunodiagnostics, molecular diagnostics, and others. Among them, the immunodiagnostics segment held a dominant share of the market in 2021. Immunodiagnostics is a technique of detection by using the ability of antibodies to bind to an antigen specifically. Factors such as the high efficiency of the technique, its cost-effective method of diagnostics, and it provides fast results are responsible for the dominating share of the segment.

Based on the animal type, the market has been categorized into companion animals and food-producing animals. Among them, the companion animals segment is anticipated to witness the fastest growth in the market. The increasing adoption of the companion animals such as dogs and cats is an important reason for the growth of the companion animal segment. For instance, according to the Zebra survey, 12.8% of Americans adopted a pet in 2020.

Based on the infection type, the market has been categorized into bacterial infections, viral infections, parasitic infections, and others. Among them, the parasitic infections segment holds a prominent share of the market. This is mainly owing to the increasing number of parasitic infections such as Ehrlichiosis and helminths in animals.

For a better understanding of the market adoption of the veterinary infectious disease diagnostics industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America is anticipated held a dominant market share in 2020. This is mainly due to the initiative taken by governmental organizations, higher adoption of pets, and favorable pet insurance policies. For instance, as per NAPHIA's 2022 State of the Industry Report, more than 4.41 million pets were insured in North America in 2021, up from 3.45 million in 2020.

Some of the major players operating in the market are BIOMERIEUX; Heska Corporation; IDEXX; Innovative Diagnostics; INDICAL BIOSCIENCE GmbH; Neogen Corporation; Randox Laboratories Ltd.; Thermo Fisher Scientific; Virbac.; and Zoetis.